Navigation Links
Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer

with DNA damaging agents such as radiation and some types of chemotherapy can induce genetic changes that give rise to additional tumors.

About ADVEXIN

ADVEXIN p53 therapy is a targeted molecular therapy with broad applicability in a wide range of tumor types and clinical settings because it targets one of the most fundamental and common molecular defects, abnormal p53 tumor suppressor function, associated with cancer initiation, progression and treatment resistance. Prognostic biomarkers can identify patients most likely to respond to ADVEXIN. ADVEXIN has demonstrated clinical activity in a number of solid tumor types in multiple phase 1, 2 and 3 clinical trials conducted worldwide.

About Introgen Therapeutics, Inc.

Introgen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. Introgen is developing molecular therapeutics, immunotherapies, vaccines and nano-particle therapies to treat a wide range of cancers using tumor suppressors and cytokines. Introgen maintains integrated research, development, manufacturing, clinical and regulatory departments and operates multiple manufacturing facilities including a commercial scale cGMP manufacturing facility.

Statements in this release that are not strictly historical may be "forward-looking" statements, including those relating to Introgen's future success with its ADVEXIN clinical development program for the treatment of patients with Li-Fraumeni Syndrome. The actual results may differ from those described in this release due to risks and uncertainties that exist in Introgen's operations and business environment, including Introgen's stage of product development and the limited experience in the development of gene-based drugs in general, dependence upon proprietary technology and the current competitive environment, history of operating losses and ac
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Preclinical Studies Identify Novel Approach for Enhancing the Anticancer Activity of Introgens INGN 241
2. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
5. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
6. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
7. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
8. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
9. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
10. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
11. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy

Post Your Comments:
(Date:11/6/2009)...-- Repossessions and liquidations of trucking equi...09 declined as compared to similar figures from 20... Quarterly Index (NQI). The figures, culled from ...ons and orderly liquidations, also indicated a ris...ing equipment, offering mixed news on the health t...
(Date:11/6/2009)...FirstCall/ -- Derma Sciences, Inc. (OTC Bullet... products, announced plans to release its third qu...er 16, 2009. The Company will hold a conference ca...m EST. Interested parties should call (866) 788-05...ith passcode 81416481 to access the call. You may ...
(Date:11/6/2009).../ -- Philips Respironics applauds the efforts of t...) to raise awareness about an important public hea...s release of the first-ever government study to mo...is a milestone in quantifying the size and scope o...ustry leader and sleep therapy manufacturer, Phili...
Breaking Medicine Technology:NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2NHC Group CEO Paul Mirabelle Announces National Hearing Care 26apos 3Bs Proposal to Buy Bay Audiology Approved 59256 1Study of DuraPrep versus chlorhexidine 59252 1Study of DuraPrep versus chlorhexidine 59252 2A trees response to environmental changes 3A What can we expect over the next 100 years 3F 10314 1A trees response to environmental changes 3A What can we expect over the next 100 years 3F 10314 2A trees response to environmental changes 3A What can we expect over the next 100 years 3F 10314 3
.... 8 Johnson & Johnson Pharmaceutical,Research & D...Phase III,trial that showed that investigational a...e 86% of patients with diabetic foot infections --...hicillin-resistant Staphylococcus,aureus (MRSA). ...ng of the Infectious,Disease Society of America (I...
...t and Selective MEK inhibitor with Favorable In Vi...erties -, CARLSBAD, Calif., Oct. 8 Ardea Bioscie...n the discovery and,development of small-molecule ...cancer and inflammatory diseases, today announced ...DEA119, will be presented at,the American Associat...
Other Medicine Technology:New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections 2New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections 3New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections 4Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 3
(Date:11/8/2009)...iopharmaceuticals to be available at the Company&r... Toronto, ON (PRWEB) November 8, 20...re Biopharma Inc. today announced that the Company...utical grade freeze dryer and expects to make comm...ble for contract manufacturing of biopharmaceutica...
(Date:11/8/2009)...health advocates committed to achieving meaningful.... 7 "Tonight the U.S. H... voice of America,s families by passing the Afford...ust deliver, without delay, on the promise of mean...do, President and CEO of the National Alliance for...
(Date:11/8/2009)...Care Reform Bill ,, Critical legislation woul...ericans ,, CHICAGO, Nov. 7 /PRNewswire-USNewsw...tatives passed by a vote of 220-215, critical heal...edicare for seniors and end discrimination by insu...out of affordable health coverage. ,, The Aff...
(Date:11/7/2009)...wswire/ -- Speaker Nancy Pelosi spoke on the Hous...ble Health Care for America Act. The House will v...he Speaker,s remarks. ,, "Madam Speaker, today...tion and for American families. For nearly a cent...hy -- as far back as Teddy Roosevelt -- have calle...
(Date:11/7/2009).../ -- Members of the AMA are trying a last-minute t...ing the AMA,s support of HR 3962. ,, "We want ...their PATIENTS, not the leadership of the AMA," sa...ciation of American Physicians and Surgeons, and T...oups. ,, "If the AMA leadership ignores the pu...
Breaking Medicine News(10 mins):Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4
...le billions of dollars are spent,yearly on strolle...p,infants stay safe and comfortable -- parents oft... one place where their babies spend the,majority o.../www.sylvane.com ), offers these tips,to help pare...
...n provides a 360-degree social conversation on hea...emselves and help others, SANTA MONICA, Calif., J...ia company, and the Lance Armstrong Foundation (LA...elp,others by offering online tools and relevant c...
...6 Following a study,indicating that strong attitu...he Chinese community, Asian & Pacific Islander Wel...d "TalkAIDS" to address this issue of,stigma in th...t think AIDS,has a voice? Well it does, and often,...
...the Annual Meeting of,the American Medical Associa...to a position on the AMA,s Council of Ethical and ..., The Council on Ethical and Judicial Affairs (CE...orts that analyze,and address timely ethical issue...
..., the brew could boost heart health, study finds ,... news for coffee lovers: Drinking up to six cups a...won,t shorten your life span, a new study shows. ,...tion does not increase the risk of death and proba...
...P. Serota, President and CEO Blue Cross and Blue,S...Serota,president and chief executive officer of th...released the following statement regarding today,s...n,Max Baucus (D-MT) and Ranking Member Chuck Grass...
Other Medicine News:Health News:Tips to Achieve a Healthier, More Restful Nursery 2Health News:Lance Armstrong Foundation and Demand Media Launch LIVESTRONG.COM 2Health News:Lance Armstrong Foundation and Demand Media Launch LIVESTRONG.COM 3Health News:Lance Armstrong Foundation and Demand Media Launch LIVESTRONG.COM 4Health News:TalkAIDS: A&PI Wellness Center Launches a New Anti-Stigma Campaign With International Star Joan Chen 2Health News:Coffee Drinkers Might Live Longer 2Health News:Coffee Drinkers Might Live Longer 3Health News:Making Healthcare More Affordable Is a National Priority 2
Reusable Double Dilators
Contour Design Eyelid Implants (Gold)
Ptose-Up Ptosis Sling (3mm)
Bioceramic Orbital Implants
Medicine Products: